Riskpilot← Back to searchSign inGet full accessLajf Kurs & Terapi AB
ABActiveOrg 5564972593Vedmyra 117General medical practice activities · NACE 8621Est. 19941 employees
Revenue 2024
SEK 0
EBITDA margin
—
+14% vs 2023
Equity ratio
57.4%
Financial strength
Net profit 2024
SEK -31K
+31% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -28K | +14% |
| Net profit | SEK -31K | +31% |
| Total assets | SEK 65K | -23% |
| Equity | SEK 37K | -45% |
| Employees | 1 | — |
Legal name
Lajf Kurs & Terapi AB
Org number
5564972593
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 november 1994
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva medicinsk konsultverksamhet som bland annat inkluderar läkarpraktik, fysio- och psykoterapi verksamhet, kurs och föredragsverksamhet, bok- och skivförlagsverksamhet, driva egen kursgård, hästhantering, uppfödning av hästar, ridterapi samt idka därmed förenlig verksamhet.
Address
Vedmyra 117
Phone
+4665316900
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 166 | 85 | 67 | 0 | 0 |
| Staff expenses | — | — | −16 | −10 | −10 |
| EBITDA | 81 | −43 | −44 | −33 | −28 |
| Depreciation & amort. | −10 | −13 | −13 | −13 | −4 |
| EBIT | 71 | −56 | −56 | −45 | −32 |
| Net financials | — | −1 | −1 | 0 | 1 |
| Profit before tax | 47 | −34 | −57 | −45 | −31 |
| Tax | −10 | −0 | — | — | — |
| Net profit | 37 | −34 | −57 | −45 | −31 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 240 | 191 | 134 | 84 | 65 |
| Equity | 204 | 170 | 113 | 68 | 37 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 13 | 21 | 21 | 16 | 28 |
| Total debt | 13 | 21 | 21 | 16 | 28 |
EBITDA margin
-2811300.0%
This company
15.8%
Market median
-17793138% vs market
20202024
Equity ratio
57.4%
This company
38.2%
Market median
+50% vs market
20202024
Return on equity
-82.6%
This company
18.4%
Market median
-549% vs market
20202024
Net profit margin
-3093500.0%
This company
8.1%
Market median
-38191458% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JP Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
LF Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lajf Kurs & Terapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jannie Pevik | Deputy Chief Executive Officer | 0 companies |
| Leif Folke Thomas Fasth | Chief Executive Officer | 0 companies |